Total Xenoestrogen Body Burden in Relation to Mammographic Density, a Marker of Breast Cancer Rlisk

University of Wisconsin, Madison270 enrolled

Overview

Mammographic density is sensitive to estorgen exposure and constitutes a strong intermediate maker of breast cancer risk. We hypothesize that women with higher serum xenoestrogen levels will have greater mammographic density.

Study Type

OBSERVATIONAL

Enrollment

270

Conditions

Breast Cancer Risk

Eligibility

Sex: FEMALEMin age: 55 YearsMax age: 70 Years

Medical Language ↔ Plain English

Inclusion Criteria: * 55-70 years of age, Post menopausal Exclusion Criteria: * If they have ever used hormone replacment therapy or have ever used Tamoxifen or Raloxifene, Diag. with breast cancer have had breast implants or have had a mastectomy/

Locations (1)

University of Wisconsin Hospital

Madison, Wisconsin, United States

Outcomes

Primary Outcomes

Characterize the distribution of total xenoestrogen burden and identify important source of xenoestrogen exposure among a clinic-based sample of postmenopausal women.

Time frame: 1 year

Secondary Outcomes

Evaluate the association of total xenoestorgen exposure with mammographic density.

Time frame: 1 year

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.